Browsing Category
Healthcare Industry News
2467 posts
How Lumee Oxygen could influence intraoperative decision-making in limb ischemia
Profusa, Inc. raises guidance as Lumee Oxygen gains traction in Europe. Discover how real-time oxygen data could reshape limb ischemia surgery.
Why WestFax is betting that healthcare automation starts with fax, not EHR replacement
Discover how WestFax Comprehend uses AI to automate healthcare document intake while preserving existing workflows and compliance. Read the full analysis.
Why Science Corporation’s ecosystem deal with Neurosoft Bioelectronics could reshape how brain interfaces scale
Science Corporation’s BCI ecosystem deal with Neurosoft Bioelectronics hints at a platform shift in brain-computer interfaces. Read why this matters now.
Exact Sciences stockholders approve Abbott acquisition, clearing final hurdle in $21bn cancer diagnostics deal
Exact Sciences stockholders approve Abbott’s $21 billion acquisition. Find out how the deal could reshape cancer diagnostics and investor strategy.
Will pneumatic tooth movement gain traction in cosmetic orthodontics?
Dror Ortho-Design secures FDA clearance for ZSmile. Will pneumatic orthodontics reshape cosmetic aligner economics? Read the full executive analysis.
How FDA approval of SIGNA MRI upgrades could influence imaging economics
GE HealthCare wins FDA approval for SIGNA MRI upgrades. Explore how this could reshape hospital imaging economics and capital strategy.
Is Target Corporation the ultimate stress test for clean-label supplement brands like Just Ingredients?
Just Ingredients enters Target Corporation stores nationwide. Find out what this move means for clean-label supplements and mass retail wellness trends.
Dr. Reddy’s (NSE: DRREDDY) acquires Progynova and Cyclo-Progynova to enter India’s hormone replacement therapy market
Dr. Reddy’s Laboratories Limited enters hormone replacement therapy with a $32 million India acquisition. Find out why this move matters now.
Can Danaher Corporation unlock new hospital economics with its $9.9bn Masimo Corporation bet?
Danaher Corporation to acquire Masimo Corporation for $9.9B in cash. Discover what this means for hospital diagnostics and investor strategy. Read more.
What Galderma Group AG’s new CFO appointment reveals about its next phase as a global dermatology company
Galderma Group AG appoints a new CFO as it enters its post-IPO phase. Find out what the leadership change signals for investors and strategy.